H7N9 influenza virus neutralizing antibodies that possess few somatic mutations.
Thornburg, N.J., Zhang, H., Bangaru, S., Sapparapu, G., Kose, N., Lampley, R.M., Bombardi, R.G., Yu, Y., Graham, S., Branchizio, A., Yoder, S.M., Rock, M.T., Creech, C.B., Edwards, K.M., Lee, D., Li, S., Wilson, I.A., Garcia-Sastre, A., Albrecht, R.A., Crowe, J.E.(2016) J Clin Invest 126: 1482-1494
- PubMed: 26950424 
- DOI: 10.1172/JCI85317
- Primary Citation of Related Structures:  
5V2A - PubMed Abstract: 
Avian H7N9 influenza viruses are group 2 influenza A viruses that have been identified as the etiologic agent for a current major outbreak that began in China in 2013 and may pose a pandemic threat. Here, we examined the human H7-reactive antibody response in 75 recipients of a monovalent inactivated A/Shanghai/02/2013 H7N9 vaccine ...